Drug price fixing allegation may be increasingly problematic for makers: Analyst

2:36 PM ET Mon, 13 May 2019

David Maris, research analyst at Wells Fargo, joins CNBC's "Power Lunch" team to discuss how big drug makers are trading amid allegations of price fixing.